天目湖(603136) - 2025 Q3 - 季度财报
2025-10-26 07:50
江苏天目湖旅游股份有限公司 2025 年第三季度报告 证券代码:603136 证券简称:天目湖 江苏天目湖旅游股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误 导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 单位:元 币种:人民币 | | 本报告期 | 本报告期比上年同 | 年初至报告期 | 年初至报告期末比 | | --- | --- | --- | --- | --- | | 项目 | | 期增减变动幅度 (%) | 末 | 上年同期增减变动 幅度(%) | | 营业收入 | 139,503,249.95 | -1.23 | 385,817,300.34 | -4.65 | | 利润总额 ...
无锡银行(600908) - 2025 Q3 - 季度财报
2025-10-26 07:50
Financial Performance - Total revenue for the third quarter reached CNY 1,120,308,000, an increase of 4.88% compared to the same period last year[4] - Net profit attributable to shareholders was CNY 453,401,000, reflecting a growth of 4.57% year-over-year[4] - The total profit amounted to CNY 512,623,000, which is a 4.05% increase from the previous year[4] - Net profit for the first three quarters of 2025 reached CNY 1,835,410 thousand, a rise of 3.7% compared to CNY 1,769,758 thousand in the same period of 2024[16] - Basic earnings per share for the first three quarters of 2025 were CNY 0.82, compared to CNY 0.80 in the same period of 2024[17] - Total comprehensive income amounted to CNY 1,604,465 thousand, a decrease from CNY 1,815,929 thousand year-over-year[24] - The net profit for the first three quarters of 2025 was CNY 1,828,839, an increase of 3.8% compared to CNY 1,762,177 in 2024[23] Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY 7,011,326,000, showing a decrease of 23.70% compared to the previous year[4] - Net cash flow from operating activities for the first three quarters of 2025 was CNY 7,011,326, a decrease of 23.8% compared to CNY 9,189,399 in the same period of 2024[18] - Net cash flow from operating activities was CNY 6,978,001 thousand, down from CNY 8,863,531 thousand in the previous year[25] - The net cash flow from investment activities for the first three quarters of 2025 was negative CNY 2,925,694, a decline from a positive CNY 1,334,491 in 2024[18] - The net cash flow from investment activities was negative at CNY -2,925,330 thousand, contrasting with a positive CNY 1,334,490 thousand in the previous year[25] Assets and Liabilities - Total assets at the end of the reporting period were CNY 277,410,695,000, representing an 8.03% increase from the end of the previous year[5] - Total assets increased to CNY 277,410,695 thousand as of September 30, 2025, up from CNY 256,801,132 thousand at the end of 2024, representing a growth of approximately 8.3%[13] - The bank's total liabilities amounted to CNY 252,940,314 thousand as of September 30, 2025, compared to CNY 233,434,958 thousand at the end of 2024, reflecting an increase of approximately 8.4%[14] - The total liabilities as of September 30, 2025, were CNY 251,786,183, up from CNY 232,406,476 at the end of 2024, indicating a growth of 8.4%[20] - Total deposits reached CNY 237,362,563 thousand, an increase from CNY 212,480,374 thousand at the end of 2024[28] Loans and Advances - The bank's loan and advance amounts reached CNY 163,435,893 thousand, up from CNY 151,214,555 thousand, marking an increase of about 8.1%[13] - Total loans increased to CNY 168,910,734 thousand, up from CNY 156,619,334 thousand at the end of 2024[28] - The net increase in loans and advances for the first three quarters of 2025 was CNY 12,841,597, compared to CNY 11,674,489 in 2024, representing a growth of 10.0%[18] Income and Ratios - Net interest income for the first three quarters of 2025 was CNY 2,610,166 thousand, slightly up from CNY 2,571,255 thousand in 2024, indicating a growth of 1.5%[16] - The capital adequacy ratio was reported at 14.03%, slightly down from 14.07% at the end of 2024[31] - The core tier 1 capital adequacy ratio stood at 11.77% as of September 30, 2025, compared to 11.79% at the end of 2024[30] - The cost-to-income ratio improved to 27.17% from 30.75% in the previous year[31] - The non-performing loan ratio remained stable at 0.78% as of September 30, 2025, unchanged from the end of 2024[31] Other Information - The weighted average return on equity was not specified but is calculated on an annualized basis[5] - Non-recurring gains and losses totaled CNY 787,000 for the quarter, with government subsidies contributing CNY 1,784,000[7] - The company has not reported any significant changes in shareholder structure or major strategic initiatives during the quarter[12] - There were no new product launches or technological advancements mentioned in the report[12]
药明康德(603259) - 2025 Q3 - 季度财报


2025-10-26 07:50
无锡药明康德新药开发股份有限公司 2025 年第三季度报告 无锡药明康德新药开发股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误 导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人 Ge Li(李革)、主管会计工作负责人施明及会计机构负责人(会计主管人员)孙瑾保 证季度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 释义 | 常用词语释义 | | | | --- | --- | --- | | 公司、本公司 | 指 | 无锡药明康德新药开发股份有限公司 | | 报告期、本报告期 | 指 | 2025年7月1日至2025年9月30日 | | 报告期末、本报告期末 | 指 | 2025 年 9 月 30 日 | | 股份 | 指 | 本公司股本中每股面值人民币 1.00 元的普通股,包括 A 股及 H | | | | 股 | | 元、万元、亿元 | 指 | ...
伟测科技(688372) - 2025 Q3 - 季度财报
2025-10-26 07:50
证券代码:688372 证券简称:伟测科技 转债代码:118055 转债简称:伟测转债 上海伟测半导体科技股份有限公司 2025 年第三季度报告 上海伟测半导体科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误 导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 单位:元 币种:人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 448 ...
郴电国际(600969) - 2025 Q3 - 季度财报
2025-10-26 07:50
Financial Performance - The company's operating revenue for the third quarter was CNY 1,122,423,135.36, a decrease of 18.92% compared to the same period last year[3]. - The total profit for the quarter was CNY 65,077,268.59, down 22.24% year-on-year[3]. - The net profit attributable to shareholders was CNY 55,051,872.41, an increase of 36.09% compared to the same period last year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 55,312,696.60, up 87.34% year-on-year[3]. - The basic earnings per share for the quarter was CNY 0.1488, reflecting a 36.14% increase compared to the same period last year[3]. - Net profit for the first three quarters of 2025 was CNY 110,784,047.24, compared to CNY 117,736,126.22 in 2024, indicating a decline of 5.88%[21]. - Earnings per share for the first three quarters of 2025 was CNY 0.2188, an increase from CNY 0.1634 in the same period of 2024, representing a growth of 33.86%[21]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 14,281,732,103.86, a decrease of 1.55% from the end of the previous year[3]. - Total current assets as of September 30, 2025, amount to ¥2,550,659,018.24, a decrease from ¥2,692,705,264.72 at the end of 2024[14]. - Total non-current assets are valued at ¥11,731,073,085.62, down from ¥11,814,001,675.06[15]. - Total liabilities as of the latest reporting period amounted to CNY 10,286,616,826.61, a decrease from CNY 10,623,936,667.48 in the previous period[16]. - Total equity attributable to shareholders increased to CNY 3,640,029,449.23 from CNY 3,554,782,773.59, marking a growth of 2.40%[16]. - Long-term borrowings decreased to CNY 5,990,918,576.46 from CNY 6,472,354,188.63, reflecting a reduction of 7.43%[16]. Cash Flow - Cash generated from operating activities in the first three quarters of 2025 was CNY 3,362,000,990.56, slightly down from CNY 3,368,518,818.05 in 2024[23]. - The net cash flow from operating activities was ¥879,005,326.21, a decrease of 20% compared to ¥1,097,490,401.34 in the previous period[24]. - Cash inflow from investment activities totaled ¥184,988,601.95, while cash outflow was ¥553,268,347.64, resulting in a net cash flow of -¥368,279,745.69[24]. - The net cash flow from financing activities was -¥713,773,198.93, compared to -¥174,046,978.54 in the previous period, indicating a significant increase in cash outflow[26]. - The total cash and cash equivalents at the end of the period were ¥1,409,705,457.94, down from ¥1,738,566,225.84 at the end of the previous period[26]. - The company reported a total cash inflow from operating activities of ¥3,705,189,260.41, compared to ¥4,390,303,566.64 previously[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 20,011[11]. - The largest shareholder, Chenzhou Development Investment Group Co., Ltd., holds 59,681,400 shares, accounting for 16.13% of total shares[11]. Other Financial Metrics - The company reported a significant increase in contract assets, up 764.33% year-on-year, attributed to an increase in receivables for project warranty deposits[7]. - The company experienced a 79.56% increase in prepayments, primarily due to increased advance payments for material procurement[7]. - The company recorded a non-recurring loss of CNY 259,345.65 for the quarter, influenced by various factors including government subsidies and asset disposal gains[6]. - The weighted average return on equity increased to 1.53%, up 0.42 percentage points from the previous year[3]. - Research and development expenses for the first three quarters of 2025 were CNY 587,242.02, up from CNY 368,617.50 in 2024, indicating an increase of 59.47%[20]. - The company reported an investment income of CNY 49,686,058.60 for the first three quarters of 2025, down from CNY 64,544,712.79 in 2024, a decrease of 23.06%[20]. - The company has received a civil ruling dismissing a lawsuit against it, which may impact future operations positively[13]. - The company did not apply new accounting standards for the current reporting period[27].
天益医疗(301097) - 2025 Q3 - 季度财报
2025-10-26 07:36
宁波天益医疗器械股份有限公司 2025 年第三季度报告 证券代码:301097 证券简称:天益医疗 公告编号:2025-054 宁波天益医疗器械股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 宁波天益医疗器械股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入(元) | 159,734,944.74 | ...
久远银海(002777) - 2025 Q3 - 季度财报
2025-10-26 07:35
Financial Performance - The company's operating revenue for Q3 2025 was CNY 247.72 million, a decrease of 9.43% compared to CNY 273.52 million in the same period last year[5] - Net profit attributable to shareholders for Q3 2025 reached CNY 12.84 million, representing a significant increase of 134.12% from CNY 7.58 million year-on-year[5] - The total profit for the period from January to September 2025 reached 42,789,107.30, representing a 151.66% increase compared to the same period in 2024[11] - The company's net profit for the current period is CNY 41,587,572.05, a significant increase from CNY 11,703,966.47 in the previous period, representing a growth of approximately 255%[22] - Operating profit rose to CNY 46,815,214.64, compared to CNY 15,408,673.90 in the previous period, marking an increase of approximately 204%[22] - The total revenue from operating activities reached CNY 845,865,790.01, up from CNY 799,647,329.36, indicating a growth of about 5.8%[25] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period increased by 131.24%, amounting to CNY 10.11 million compared to CNY 32.36 million in the previous year[5] - The company reported a net cash flow from operating activities of 10,109,589.75, a significant turnaround from a negative cash flow of -32,364,362.20 in the previous year, marking a 131.24% improvement[11] - The cash received from other operating activities increased by 125.86% to 26,425,713.88, driven by the recovery of deposits[11] - The company's cash and cash equivalents decreased by 38.15%, from CNY 675.44 million at the beginning of the year to CNY 417.73 million[10] - The cash and cash equivalents at the end of the period decreased to CNY 339,307,548.99 from CNY 373,050,359.95, a decline of about 9.1%[25] - The company incurred a net cash outflow from investing activities of CNY -232,311,810.30, compared to CNY -201,539,472.38 in the previous period[25] Assets and Liabilities - Total assets as of September 30, 2025, were CNY 2.66 billion, reflecting a decrease of 1.21% from CNY 2.69 billion at the end of the previous year[5] - The company's total liabilities decreased by 55.31% to 3,078,913.44, mainly due to a reduction in long-term lease liabilities[11] - The total assets decreased to RMB 2,660,323,323.71 from RMB 2,692,964,862.04, a decline of about 1.2%[20] - The total liabilities decreased to RMB 871,411,978.06 from RMB 884,206,432.74, a reduction of approximately 1.5%[20] - The total equity attributable to the parent company decreased to RMB 1,653,017,586.10 from RMB 1,671,463,134.50, a decline of about 1.1%[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 56,082, with no preferred shareholders[13] - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holds a 26.29% stake, amounting to 107,310,403 shares[13] - The company received a notice regarding potential changes in the actual controller due to equity reform plans from its major shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd.[15] Research and Development - Research and development expenses increased by 48.69% to 117,899,450.95, reflecting the company's commitment to enhancing R&D investment[11] - The company is actively involved in research and development of new products and technologies, although specific details were not disclosed in the conference call[21] - Research and development expenses increased to CNY 117,899,450.95 from CNY 79,293,433.39, reflecting a growth of about 48.6%[22] Other Financial Metrics - Basic earnings per share for Q3 2025 were CNY 0.0300, up 200.00% from CNY 0.0200 in the same quarter last year[5] - Basic and diluted earnings per share increased to CNY 0.10 from CNY 0.04, representing a 150% increase[23] - The company reported a significant increase in non-recurring gains and losses, totaling CNY 2.82 million for the current period[8] - Investment income rose by 44.36% to 7,688,160.87, primarily due to increased interest from time deposits[11] - The company experienced a 64.92% decrease in tax payable, totaling 8,965,661.19, due to the payment of prior period corporate income tax and VAT[11]
佳力奇(301586) - 2025 Q3 - 季度财报
2025-10-26 07:35
Financial Performance - The company's revenue for Q3 2025 was ¥132,601,928.01, representing a decrease of 20.18% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2025 was ¥4,737,717.09, down 72.22% year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥3,067,950.18, a decline of 80.07% compared to the previous year[5] - Total operating revenue for the current period reached ¥564,550,765.34, a 29.4% increase from ¥436,062,017.42 in the previous period[20] - Net profit attributable to the parent company was ¥42,469,418.98, a decrease of 45.9% compared to ¥78,599,133.78 in the previous period[21] - Basic and diluted earnings per share decreased to ¥0.5118 from ¥1.2179 in the previous period[21] Assets and Liabilities - The total assets at the end of Q3 2025 reached ¥1,668,866,259.22, an increase of 5.94% from the end of the previous year[5] - Current assets totaled ¥1,203,098,942.49, up from ¥1,113,030,231.76, indicating an increase of about 8.1%[18] - Total liabilities increased to ¥391,883,377.16 from ¥324,889,312.02, which is an increase of about 20.6%[19] - The company's equity attributable to shareholders reached ¥1,276,982,882.06, up from ¥1,250,431,516.61, reflecting a growth of approximately 2.1%[19] - Cash and cash equivalents decreased to ¥385,133,754.78 from ¥586,625,535.59, representing a decline of approximately 34.3%[18] Cash Flow - The company's cash flow from operating activities for the year-to-date was negative at ¥80,388,419.88, a decrease of 8.25% year-on-year[5] - Cash flow from operating activities showed a net outflow of ¥80,388,419.88, compared to a net outflow of ¥74,260,505.91 in the previous period[23] - Investment activities resulted in a net cash outflow of ¥60,650,498.31, compared to a net outflow of ¥17,206,946.62 in the previous period[23] - Financing activities generated a net cash outflow of ¥45,281,235.35, a significant decrease from a net inflow of ¥402,087,956.68 in the previous period[23] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 10,034, indicating a stable shareholder base[10] - The company has a total of 11,881,357 restricted shares held by the controlling shareholder, Lu Qiang, which will be released on August 28, 2027[14] - The largest unrestricted shareholder is the Huakong Investment Fund with 10,546,875 shares, which will be released on August 28, 2025[14] - The company has 9,000,000 shares held by Suzhou Guangrong Management Consulting Partnership, which are also subject to a lock-up until August 28, 2027[14] - The total number of shares held by the top 10 unrestricted shareholders is significant, indicating concentrated ownership[12] - The overall shareholder structure reflects a mix of institutional and individual investors, with a focus on long-term investment strategies[12] Research and Development - Research and development expenses increased by 33.24% to ¥36,888,007.62 for the year-to-date, reflecting a focus on innovation[9] - Research and development expenses increased to ¥36,888,007.62, up from ¥27,684,488.82 in the previous period, reflecting a focus on innovation[20] Operational Costs - The company's gross profit margin decreased significantly due to rising operating costs, which increased by 51.67% to ¥444,891,650.60 for the year-to-date[9] - Total operating costs increased to ¥516,768,408.20, up 46.4% from ¥352,865,423.40 in the previous period[20]
宇晶股份(002943) - 2025 Q3 - 季度财报
2025-10-26 07:35
湖南宇晶机器股份有限公司 2025 年第三季度报告 证券代码:002943 证券简称:宇晶股份 公告编号:2025-053 湖南宇晶机器股份有限公司 重要内容提示: 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗 漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真 实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 湖南宇晶机器股份有限公司 2025 年第三季度报告 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述 或重大遗漏。 一、主要财务数据 (一) 主要会计数据和财务指标 | 项目 | 本报告期金额 | 年初至报告期期末金额 | 说明 | | --- | --- | --- | --- | | 非流动性资产处置损益(包括已计提 | -261,485.45 | -246,640.14 | | | 资产减值准备的冲销部分) | | | | | 计入当期损益的政府补助(与公司正 常经营业务密切相关、符合 ...
惠通科技(301601) - 2025 Q3 - 季度财报
2025-10-26 07:35
扬州惠通科技股份有限公司 2025 年第三季度报告 扬州惠通科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、完 整。 3.第三季度财务会计报告是否经过审计 □是 否 1 证券代码:301601 证券简称:惠通科技 公告编号:2025-064 扬州惠通科技股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末比上 年初至报告期末 | | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入(元) | 83,506,694.86 | 30.80% | 360,7 ...